Clinical Trials Logo

Clinical Trial Summary

. Treatment with dequalinium chloride vaginal tablets for 6 days had a cure rate lower than expected; only 37% of patients were considered cured one month after treatment.


Clinical Trial Description

This is the first study to utilize a molecular diagnostic test as a test of cure for bacterial vaginosis. The Nugent score is a reliable method for diagnosing bacterial vaginosis, but similar to traditional clinical diagnostic methods, it is not equally reliable when utilized as a test of cure. This study demonstrated that molecular diagnostic testing can be used as a test of cure and this is the first molecular test that can do that. Treatment with dequalinium chloride vaginal tablets for 6 days had a cure rate lower than expected; only 37% of patients were considered cured one month after treatment. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04057482
Study type Observational
Source Skaraborg Hospital
Contact
Status Completed
Phase
Start date May 2015
Completion date April 2018

See also
  Status Clinical Trial Phase
Terminated NCT03954990 - Treatment of Bacterial Vaginosis Prior to Active Labor and Infectious Morbidity Phase 1
Completed NCT04329338 - Effects of Lactobacillus Pentosus KCA1 on the Gut and Vaginal Microbiome of Women With Bacterial Vaginosis N/A
Completed NCT03837015 - Estrogen, Probiotics and Vaginal Health to Prevent HIV Infection in ACB Women Phase 1
Completed NCT03937869 - Evaluate the Safety of a Single Oral Dose of Solosecâ„¢ (Secnidazole) 2g for the Treatment of Adolescent Girls With BV Phase 4
Completed NCT03878511 - Therapeutic Lactose to Support Vaginal Microbiota N/A
Not yet recruiting NCT04846361 - Vaginal Hygiene Wash as Adjunct Treatment in Bacterial Vaginosis N/A
Completed NCT04393857 - The Temporo-spatial Dynamics of Genital Tract Microbiota - an Observational Study in Oocyte Donors
Completed NCT04414527 - Effects of Video-based Health Education on Maternal and Child Health in Ethiopia N/A
Recruiting NCT04807842 - Multi-Gyn ActiGel Plus for Treatment of Bacterial Vaginosis N/A
Recruiting NCT05166746 - The Effect of Clindamycin and a Live Biotherapeutic on the Reproductive Outcomes of IVF Patients With Abnormal Vaginal Microbiota Phase 2
Completed NCT04189744 - The ASPIRE Trial - Aiming for Safe Pregnancies by Reducing Malaria and Infections of the Reproductive Tract Phase 3
Recruiting NCT04517487 - Vaginal Microbiome Transplantation for Recurrent Bacterial Vaginosis N/A
Recruiting NCT04885556 - Evaluation of a Novel Female Hygiene Device for Postcoital Discomfort N/A
Terminated NCT04578015 - A Randomized Controlled Trial of Treatment of Bacterial Vaginosis Phase 4
Completed NCT06104098 - A User Study With Vernivia® for Bacterial Vaginosis. N/A